Paracrine and exosome-mediated signaling factors

The concept of paracrine and exosome-mediated signaling represents a shift in regenerative medicine from direct cell replacement to the modulation of the host environment via secreted factors. This mechanism is not a single molecular entity but a complex secretome consisting of cytokines, growth factors, and extracellular vesicles (exosomes) that carry proteins and regulatory RNAs (Vizoso et al., 2017, Int J Mol Sci). These components act pleiotropically on multiple cell types, including immune cells, endothelial cells, and fibroblasts, to suppress inflammation and promote tissue repair (Gnecchi et al., 2016, Circ Res). This mechanism is the primary driver of the therapeutic efficacy observed in mesenchymal stem cell (MSC) therapies and is currently being developed as cell-free therapeutics using isolated exosomes or conditioned media (Kalluri & LeBleu, 2020, Science). In clinical contexts, such as treating myocardial infarction or acute respiratory distress syndrome (ARDS), these factors work in concert to reduce fibrosis and stimulate angiogenesis (Timmers et al., 2011, Stem Cell Rev). However, the lack of a single discrete target complicates drug development, as it necessitates complex potency assays and faces challenges in manufacturing consistency and regulatory characterization (Gimona et al., 2017, Front Immunol).

Other names

SecretomeExtracellular vesiclesParacrine factorsExosome-mediated signalingMSC-derived secretomeCell-free secretome therapy

Modulation of the host microenvironment through the delivery of bioactive molecules (cytokines, chemokines, growth factors, and miRNAs) that act on multiple recipient cell types to promote repair and suppress inflammation.